These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
152 related items for PubMed ID: 12862465
1. D-Ala-D-lac binding is not required for the high activity of vancomycin dimers against vancomycin resistant enterococci. Jain RK, Trias J, Ellman JA. J Am Chem Soc; 2003 Jul 23; 125(29):8740-1. PubMed ID: 12862465 [Abstract] [Full Text] [Related]
2. Binding of a dimeric derivative of vancomycin to L-Lys-D-Ala-D-lactate in solution and at a surface. Rao J, Yan L, Lahiri J, Whitesides GM, Weis RM, Warren HS. Chem Biol; 1999 Jun 23; 6(6):353-9. PubMed ID: 10375541 [Abstract] [Full Text] [Related]
3. Importance of the structure of vancomycin binding pocket in designing compounds active against vancomycin-resistant enterococci (VRE). Jia Y, Bois-Choussy M, Malabarba A, Brunati C, Zhu J. J Antibiot (Tokyo); 2006 Sep 23; 59(9):543-52. PubMed ID: 17136887 [Abstract] [Full Text] [Related]
4. First principles investigation of vancomycin and teicoplanin binding to bacterial cell wall termini. Lee JG, Sagui C, Roland C. J Am Chem Soc; 2004 Jul 14; 126(27):8384-5. PubMed ID: 15237988 [Abstract] [Full Text] [Related]
5. Selective cleavage of D-Ala-D-Lac by small molecules: re-sensitizing resistant bacteria to vancomycin. Chiosis G, Boneca IG. Science; 2001 Aug 24; 293(5534):1484-7. PubMed ID: 11520986 [Abstract] [Full Text] [Related]
6. Quantification of the d-Ala-d-Lac-Terminated Peptidoglycan Structure in Vancomycin-Resistant Enterococcus faecalis Using a Combined Solid-State Nuclear Magnetic Resonance and Mass Spectrometry Analysis. Chang JD, Foster EE, Yang H, Kim SJ. Biochemistry; 2017 Jan 31; 56(4):612-622. PubMed ID: 28040891 [Abstract] [Full Text] [Related]
7. Design and synthesis of macrocycles active against vancomycin-resistant enterococci (VRE): the interplay between d-Ala-d-Lac binding and hydrophobic effect. Ma N, Jia Y, Liu Z, Gonzalez-Zamora E, Bois-Choussy M, Malabarba A, Brunati C, Zhu J. Bioorg Med Chem Lett; 2005 Feb 01; 15(3):743-6. PubMed ID: 15664849 [Abstract] [Full Text] [Related]
8. Partitioning the loss in vancomycin binding affinity for D-Ala-D-Lac into lost H-bond and repulsive lone pair contributions. McComas CC, Crowley BM, Boger DL. J Am Chem Soc; 2003 Aug 06; 125(31):9314-5. PubMed ID: 12889959 [Abstract] [Full Text] [Related]
9. Antibacterial activity of calozeyloxanthone isolated from Calophyllum species against vancomycin-resistant Enterococci (VRE) and synergism with antibiotics. Sakagami Y, Kajimura K, Wijesinghe WM, Dharmaratne HR. Planta Med; 2002 Jun 06; 68(6):541-3. PubMed ID: 12094300 [Abstract] [Full Text] [Related]
10. A liquid chromatography-tandem mass spectrometry assay for d-Ala-d-Lac: a key intermediate for vancomycin resistance in vancomycin-resistant enterococci. Putty S, Vemula H, Bobba S, Gutheil WG. Anal Biochem; 2013 Nov 15; 442(2):166-71. PubMed ID: 23938774 [Abstract] [Full Text] [Related]
11. Multivalent antibiotics via metal complexes: potent divalent vancomycins against vancomycin-resistant enterococci. Xing B, Yu CW, Ho PL, Chow KH, Cheung T, Gu H, Cai Z, Xu B. J Med Chem; 2003 Nov 06; 46(23):4904-9. PubMed ID: 14584941 [Abstract] [Full Text] [Related]
12. Multivalent drug design. Synthesis and in vitro analysis of an array of vancomycin dimers. Griffin JH, Linsell MS, Nodwell MB, Chen Q, Pace JL, Quast KL, Krause KM, Farrington L, Wu TX, Higgins DL, Jenkins TE, Christensen BG, Judice JK. J Am Chem Soc; 2003 May 28; 125(21):6517-31. PubMed ID: 12785792 [Abstract] [Full Text] [Related]
13. Synthesis of rigidly-linked vancomycin dimers and their in vivo efficacy against resistant bacteria. Lu J, Yoshida O, Hayashi S, Arimoto H. Chem Commun (Camb); 2007 Jan 21; (3):251-3. PubMed ID: 17299629 [Abstract] [Full Text] [Related]
14. Gain of D-alanyl-D-lactate or D-lactyl-D-alanine synthetase activities in three active-site mutants of the Escherichia coli D-alanyl-D-alanine ligase B. Park IS, Lin CH, Walsh CT. Biochemistry; 1996 Aug 13; 35(32):10464-71. PubMed ID: 8756703 [Abstract] [Full Text] [Related]
15. Quantum simulations of the structure and binding of glycopeptide antibiotic aglycons to cell wall analogues. Lee JG, Sagui C, Roland C. J Phys Chem B; 2005 Nov 03; 109(43):20588-96. PubMed ID: 16853665 [Abstract] [Full Text] [Related]
16. Antibiotic activity against urinary tract infection (UTI) isolates of vancomycin-resistant enterococci (VRE): results from the 2002 North American Vancomycin Resistant Enterococci Susceptibility Study (NAVRESS). Zhanel GG, Laing NM, Nichol KA, Palatnick LP, Noreddin A, Hisanaga T, Johnson JL, Hoban DJ, NAVRESS Group. J Antimicrob Chemother; 2003 Sep 03; 52(3):382-8. PubMed ID: 12888592 [Abstract] [Full Text] [Related]
17. Characterization of an inducible vancomycin resistance system in Streptomyces coelicolor reveals a novel gene (vanK) required for drug resistance. Hong HJ, Hutchings MI, Neu JM, Wright GD, Paget MS, Buttner MJ. Mol Microbiol; 2004 May 03; 52(4):1107-21. PubMed ID: 15130128 [Abstract] [Full Text] [Related]
18. Bactericidal activities of disinfectants against vancomycin-resistant enterococci. Sakagami Y, Kajimura K. J Hosp Infect; 2002 Feb 03; 50(2):140-4. PubMed ID: 11846542 [Abstract] [Full Text] [Related]
19. Increasing vancomycin susceptibility in vancomycin resistant enterococci by vanH promoter and ddl transformation. Choi JY, Chang KH, Lee KS, Song YG, Kim JM. J Infect; 2004 May 03; 48(4):314-9. PubMed ID: 15066332 [Abstract] [Full Text] [Related]
20. The vancomycin-nisin(1-12) hybrid restores activity against vancomycin resistant Enterococci. Arnusch CJ, Bonvin AM, Verel AM, Jansen WT, Liskamp RM, de Kruijff B, Pieters RJ, Breukink E. Biochemistry; 2008 Dec 02; 47(48):12661-3. PubMed ID: 18989934 [Abstract] [Full Text] [Related] Page: [Next] [New Search]